Enrichment analysis of genes downregulated following Plx4032 treatment
Canned Analysis
FAIR Metrics
0 evaluations
General Information
AccessionDCA00055236
TitleEnrichment analysis of genes downregulated following Plx4032 treatment
DescriptionAn enrichment analysis was performed on the top 500 most downregulated genes identified by applying the Characteristic Direction method comparing gene expression between Plx4032 treated cells and untreated control cells in the WM164 BRAF mutant Melanoma cells cell type.
Analysis URLhttp://amp.pharm.mssm.edu/Enrichr/enrich?dataset=1bwd0
Upload DateSeptember 20, 2017
Uploadermaayanlab
Metadata
Analysis Curatorcadimo
CREEDS IDdrug:2556
Cell TypeWM164 BRAF mutant Melanoma cells
Drug NamePlx4032
DrugBank IDDB05238
Organismhuman
Characteristic Direction parameters
Gene Setdownregulated
Gene Set Size500
Control SamplesGSM1322672, GSM1322673, GSM1322674
Perturbed SamplesGSM1322675, GSM1322676, GSM1322677
Tools used in the analysis
Keyword
Dataset Accession
Enrichr
Published May 2016
A comprehensive gene set enrichment analysis web server 2016 update
7759
65
Characteristic Direction
Published March 2014
A geometrical multivariate approach to identify differentially expressed genes
26829
Datasets used in the analysis
Keyword
Tool Name
GSE54711
Gene Expression Omnibus
Parent vs. Induced drug tolerant cells Microarray Analysis
7
FAIR Evaluation
Sorry, you must be signed in to evaluate this object.